Nevro to Pay Boston Scientific $20 Million in Patent Infringement Case -- Update
November 01 2021 - 8:34PM
Dow Jones News
By Kimberly Chin
Nevro Corp. is expected to pay $20 million to Boston Scientific
Corp. after a Delaware jury found that the medical device company
had infringed on two Boston Scientific patents related to the
manufacturing of a spinal cord stimulation technology, the company
said late Monday.
The jury found that Nevro infringed on two lead patents
involving the ways spinal cord stimulation technology were
manufactured. The manufacturing methods were implemented by a
third-party supplier, Nevro said. Two other Boston Scientific
patents weren't infringed.
"We disagree with the finding by the jury and plan to appeal,"
Nevro General Counsel Kashif Rashid said in a release.
The jury's decision doesn't have any commercial implications or
place any restrictions on current or future Nevro products, the
Redwood City, Calif., company said. The amount of money that will
be awarded to Boston Scientific won't have a material effect on its
business, Nevro said.
"We are gratified that the jury upheld Boston Scientific spinal
cord stimulation lead patents and recognized that Nevro should pay
for infringing those patents," a Boston Scientific spokeswoman said
in an emailed statement.
Write to Kimberly Chin at kimberly.chin@wsj.com
(END) Dow Jones Newswires
November 01, 2021 20:19 ET (00:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2023 to Apr 2024